Inogen Inc (INGN)
6.70
-0.05
(-0.74%)
USD |
NASDAQ |
Apr 22, 16:00
6.705
0.00 (0.00%)
Pre-Market: 20:00
Inogen Cash from Investing (Quarterly): 4.128M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.128M |
| September 30, 2023 | -45.79M |
| June 30, 2023 | -0.54M |
| March 31, 2023 | -17.11M |
| December 31, 2022 | -6.944M |
| September 30, 2022 | -4.755M |
| June 30, 2022 | 4.874M |
| March 31, 2022 | -4.052M |
| December 31, 2021 | -12.38M |
| September 30, 2021 | 1.154M |
| June 30, 2021 | -4.408M |
| March 31, 2021 | 0.986M |
| December 31, 2020 | -18.52M |
| September 30, 2020 | -7.969M |
| June 30, 2020 | -8.048M |
| March 31, 2020 | 8.899M |
| December 31, 2019 | 31.45M |
| September 30, 2019 | -73.68M |
| June 30, 2019 | 5.116M |
| March 31, 2019 | -6.948M |
| December 31, 2018 | 2.00M |
| September 30, 2018 | -9.519M |
| Date | Value |
|---|---|
| June 30, 2018 | -11.46M |
| March 31, 2018 | -5.989M |
| December 31, 2017 | -3.041M |
| September 30, 2017 | -5.828M |
| June 30, 2017 | -11.80M |
| March 31, 2017 | -3.765M |
| December 31, 2016 | -0.55M |
| September 30, 2016 | -10.69M |
| June 30, 2016 | -1.63M |
| March 31, 2016 | 0.942M |
| December 31, 2015 | -0.476M |
| September 30, 2015 | -6.818M |
| June 30, 2015 | -17.97M |
| March 31, 2015 | -4.04M |
| December 31, 2014 | -4.878M |
| September 30, 2014 | -3.841M |
| June 30, 2014 | -4.307M |
| March 31, 2014 | -3.228M |
| December 31, 2013 | -3.645M |
| September 30, 2013 | -5.39M |
| June 30, 2013 | -5.538M |
| March 31, 2013 | -3.569M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-73.68M
Minimum
Sep 2019
31.45M
Maximum
Dec 2019
-7.768M
Average
-4.408M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| Oragenics Inc | -1.00M |
| Palatin Technologies Inc | 9.462M |
| Oramed Pharmaceuticals Inc | 30.00M |
| vTv Therapeutics Inc | 4.404M |
| G1 Therapeutics Inc | -7.647M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.148M |
| Cash from Financing (Quarterly) | -0.014M |
| Free Cash Flow | -30.24M |
| Free Cash Flow Per Share (Quarterly) | -0.4053 |
| Free Cash Flow to Equity (Quarterly) | -9.45M |
| Free Cash Flow to Firm (Quarterly) | -9.45M |
| Free Cash Flow Yield | -19.48% |